New Disease Progression Study Findings Have Been Reported from Shengjing Hospital of China Medical University (Efficacy and Safety of Daratumumab Combined with Bortezomib and Dexamethasone Regimen in Newly-Diagnosed Multiple Myeloma Patients)

Source :: Immunotherapy Weekly. December 25, 2024, 3823
Publication Year :: 2024
Abstract: 2024 DEC 25 (NewsRx) -- By a News Reporter-Staff News Editor at Immunotherapy Weekly -- Fresh data on disease progression are presented in a new report. According to news reporting [...]

Subjects :: Medical research -- Reports
Medicine, Experimental -- Reports
Antineoplastic agents -- Research -- Complications and side effects
Central nervous system depressants -- Complications and side effects -- Research
Diseases -- Prognosis -- Development and progression -- Research -- Care and treatment -- Complications and side effects -- China
Immunotherapy -- Reports -- Research
Dexamethasone -- Research -- Complications and side effects
Multiple myeloma -- Complications and side effects -- Care and treatment -- Prognosis -- Development and progression -- Research
Antimitotic agents -- Research -- Complications and side effects
Health

Tools